WHO-GMP sourced EU-GMP partners ISO 9001:2015 49+ export markets Since 2003

Pulmicort (budesonide) is an inhaled corticosteroid for asthma, supplied as Respules for jet nebulisers and as dry powder inhalers, and it is stored at room temperature, not in a cold chain.

M Care Exports supplies hospitals, licensed importers, distributors and government tender authorities internationally, with established supply lanes into the GCC, Africa and Europe. If you are looking for Pulmicort (budesonide) Respules or inhalers, we quote the originator brand or Indian-made budesonide lines per destination, subject to the registration route and import licence there.

WhatsApp a budesonide enquiry → Send enquiry by form
WHO-GMP sourcing CDSCO licensed exporter EU-GMP capable partners Cold-chain validated (2–8°C & −25°C) CTD / eCTD dossier-ready ISO 9001:2015
Bulk supply and export terms

Budesonide exporter and bulk supplier from India.

"We need a partner for Pulmicort Respules" is a typical enquiry from a hospital pharmacy or a tender desk. M Care is a merchant-exporter, and we supply both originator or regulator-registered brands and Indian-made lines, such as Budecort, Budate and Derinide inhalers and Budecort Respules from our own catalogue. We do not claim these Indian brands are registered in any destination, so the registration route is confirmed before we quote. Budesonide is not one product. The labels we read cover a nebuliser suspension in 2 mL single-dose units (Respules) and dry powder inhalers (Pulmicort Flexhaler in the US, Pulmicort Turbohaler in the UK), and each needs its own line on the order. None of the labels we fetched requires refrigeration, so the quote turns on strength, pack, quantity, the destination's registration route and Incoterms rather than on a cold chain.

Source

WHO-GMP-certified Indian manufacturing line, named on every quote.

Minimum order

No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.

Pricing

On request. Indicative FOB or CIF quote, formal proforma on confirmation.

Incoterms

EXW, FOB, CIF, CIP or DAP.

Payment

Letter of credit (sight or usance) and telegraphic transfer.

Documentation

WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.

Shelf-life

Minimum remaining shelf-life agreed per order and confirmed on the proforma.

Response

Availability and CoPP status within two working days; pre-alert documents before dispatch.

Request a bulk quote → Send a bulk enquiry by form How bulk supply works
At a glance

Inhaled corticosteroid for asthma, sourced and documented for export.

Budesonide is an inhaled corticosteroid. The US DailyMed label for Pulmicort Respules (AstraZeneca Pharmaceuticals LP as packager) covers maintenance treatment of asthma and prophylactic therapy in children 12 months to 8 years of age, in 0.25 mg/2 mL, 0.5 mg/2 mL and 1 mg/2 mL single-dose ampoules, 30 per carton. It states the product is not indicated for the relief of acute bronchospasm. The US Pulmicort Flexhaler label covers maintenance treatment of asthma in patients 6 years of age and older, in 90 mcg (60 actuations) and 180 mcg (120 actuations) inhalers. The UK emc SmPC for Pulmicort Respules 1 mg (AstraZeneca UK Limited) lists a 0.5 mg/ml suspension with each 2 ml unit holding 1 mg, for bronchial asthma where a pressurised inhaler or dry powder formulation is unsatisfactory or inappropriate, and for croup in infants and children where hospitalisation is indicated. The UK Pulmicort Turbohaler 200 SmPC describes a breath-actuated metered dose powder inhaler for bronchial asthma, at 200 micrograms per actuation and 100 actuations per inhaler.

Active ingredient

Budesonide. Inhaled corticosteroid for asthma.

Forms and strengths

0.25 mg/2 mL single-dose Respule (US label); 0.5 mg/2 mL single-dose Respule (US label); 1 mg/2 mL single-dose Respule; 90 mcg Flexhaler, 60 actuations (US label); 180 mcg Flexhaler, 120 actuations (US label); 200 mcg per actuation Turbohaler, 100 actuations (UK SmPC).

Indications

Budesonide (Pulmicort) is an inhaled corticosteroid for asthma, supplied as Respules nebuliser suspension and as dry powder inhalers, as set out in the US and UK labelling. M Care Exports supplies originator and Indian-made lines per destination.

Administration

Inhalation, Nebulised inhalation. Nebuliser (inhalation) suspension in single-dose units; inhalation powder in a multi-dose dry powder inhaler.

Documentation

Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.

Who we supply

Hospital pharmacies, licensed importers and tender desks across our export markets.

India is our origin. We do not sell into the Indian market.

Buyers are hospital pharmacists in paediatric and respiratory units, MoH and hospital tender desks, and licensed importers and distributors internationally. Typical enquiries read "I'm looking for Pulmicort Respules for a paediatric ward" or "We need a partner for budesonide inhalers for a tender". M Care Exports supplies internationally, with established supply lanes into the GCC, Africa and Europe, and each destination has its own rules. In the UAE, product registration has been with the Emirates Drug Establishment (EDE) since 29 December 2025. Other destinations use their own regulators, such as NAFDAC in Nigeria or the MHRA in the UK. Whether the destination has registered the originator brand, accepts an Indian-made line, or needs an import under a special route depends on the destination regulator, and M Care Exports confirms the route per enquiry.

GCC registration routes

Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.

MoH registration, GCC →

UK unlicensed routes

Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.

MHRA Specials →

Tender desks

Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.

Tender response →

Dossier support

CTD documentation from the sourcing manufacturer, compiled for your regulator's format.

Dossier preparation →

Pharmacist's note

What the dispensing pharmacist checks on budesonide.

Match the nebuliser to the label before you quote. Both the US label and the UK SmPC say to use a jet nebuliser with a mouthpiece or face mask, and not an ultrasonic nebuliser. The UK SmPC specifies an air flow of 6 to 8 L/min and a fill volume of 2 to 4 ml. Mixing differs by market: the US label says the effects of mixing Respules with other nebulisable medicines have not been adequately assessed and that Respules should be given separately in the nebuliser, while the UK SmPC lists mixing with 0.9% saline and with nebuliser solutions of terbutaline, salbutamol, fenoterol, acetylcysteine, sodium cromoglycate or ipratropium bromide, using the admixture within 30 minutes. Follow the label of your destination. Storage differs by market. The US label says store upright at 20 to 25 °C, protected from light, do not freeze, and gives unused ampoules a shelf life of 2 weeks once the foil envelope is opened. The UK SmPC says do not store above 30 °C, keep in the foil envelope, store upright, protect from freezing, and use within 3 months of opening the envelope. The US label lists oral Candida infection among its warnings. It also states that Respules are not indicated for the relief of acute bronchospasm.

Regulatory & quality

The documentation pack a regulator actually asks for.

Pulmicort Respules and the inhalers are room-temperature products on the labels we fetched, so export consignments need dry, protected packing rather than a refrigerated shipper. The US Respules label says do not freeze, and the UK Respules SmPC says do not store above 30 °C, with a 24-month shelf life. Because storage wording differs between the US label and the UK SmPC, we quote against the label that matches the pack you are buying. The US label lists key warnings including oral Candida infection, impaired adrenal function when transferring from systemic corticosteroids, effects on growth in children and increased systemic exposure with strong CYP3A4 inhibitors. M Care documentation covers batch certificates of analysis, export documents and destination-aligned dossier support where the regulator asks for it. We state the source and status of each line before quoting, and make no claim for M Care itself beyond merchant-exporter documentation.

CoA and MoA, per batch

Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.

CoPP, WHO-GMP, MFG licence

Certificate of pharmaceutical product, site GMP certificate and manufacturing licence, issued by the state drug regulator and naming the actual manufacturing site.

CTD Module 3

Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.

Pack insert, labels, artwork

Destination-language patient information and labelling to the local regulator's standard, locked before shipment.

Pharmacovigilance

A named PV contact arranged in the destination market where the registration requires one.

How the enquiry works

Molecule · strength · volume · destination. One working day to a quote.

  1. Send us the specifics. Form and strength, pack preference, destination market and indicative volume for budesonide.
  2. We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
  3. Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
  4. Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
  5. After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Frequently asked

Budesonide supply, the specific questions.

What decides the landed price of Pulmicort for an importer?

We do not publish prices. The landed cost depends on whether you want the originator brand or an Indian-made budesonide line, the presentation (Respules or inhaler), strength and pack, quantity, the registration route in your destination and Incoterms. Pulmicort is stored at room temperature on the labels we fetched, so the quote does not carry a cold-chain element. M Care Exports quotes per destination once you send the presentations, volume and country.

What sets the price of Pulmicort nebuliser Respules for a hospital tender?

We give no figure here. For a nebuliser tender the drivers are the strength per 2 mL unit (the US label lists 0.25 mg, 0.5 mg and 1 mg; the UK Pulmicort Respules 1 mg SmPC covers 1 mg units), the number of units per carton, the quantity, the registration route in the destination and the delivery terms. State whether you want the originator or an Indian-made line such as Budecort Respules 0.5 mg. M Care Exports quotes per destination.

What is the generic name of Pulmicort?

The generic (non-proprietary) name is budesonide. Pulmicort is the brand name. The US and UK labels we fetched cover Pulmicort Respules, and there are also Pulmicort Flexhaler (US) and Pulmicort Turbohaler (UK) inhalers. If you are looking for budesonide by its generic name, tell us the presentation and strength, and M Care Exports confirms the line and availability for your destination.

Is there a generic version of Pulmicort Respules in the US and UK?

In the US, DailyMed lists a generic budesonide inhalation suspension from Cipla USA Inc., marketed under an Abbreviated New Drug Application, in 0.25 mg/2 mL, 0.5 mg/2 mL and 1 mg/2 mL ampoules. In the UK, the emc lists Budesonide 0.5 mg nebuliser suspension (0.25 mg/ml) from Zentiva Pharma UK Limited alongside Pulmicort Respules from AstraZeneca UK Limited. We make no statement on the EU beyond these sources.

How do Pulmicort Respules and Pulmicort Flexhaler differ on the label?

We compare on label facts only. The US Respules label covers maintenance treatment of asthma in children 12 months to 8 years of age, given by a jet nebuliser. The US Flexhaler label covers asthma maintenance in patients 6 years of age and older, dosed twice daily from an inhalation-driven multi-dose dry powder inhaler in 90 mcg or 180 mcg strengths. The Flexhaler label notes lactose containing trace levels of milk proteins. Check the label of your destination.

How are Pulmicort Respules stored, and what are the key warnings?

The US label says store upright at 20 to 25 °C, protected from light, and do not freeze. The UK SmPC says do not store above 30 °C, with a shelf life of 24 months and use within 3 months of opening the foil envelope. Key US warnings include oral Candida infection, adrenal suppression, reduced bone mineral density, effects on growth in children, glaucoma and cataracts, and paradoxical bronchospasm. The full label governs use.

Sources and review

Who stands behind this page, and where its statements come from.

Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-11-15.

This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.

Budesonide enquiry

Send the specifics. You'll have a price inside one working day.

Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.

WhatsApp the Mumbai desk → Enquiry form Back to respiratory